SCHEMBL4786516

SCHEMBL4786516

Cc1ccc(CN(C)Cc2ccccc2)c2c1CC[C@@H](NC(=O)c1ccc(OC(F)(F)F)cc1)C2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.44
CXCR3 P49682 1/20 0.44
SCN9A Q15858 5/20 0.43
KCNH2 Q12809 2/20 0.42
SCN5A Q14524 2/20 0.42
CHRM4 P08173 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
FAAH O00519 1/20 0.41
EPHX2 P34913 1/20 0.41
TAOK1 Q7L7X3 2/20 0.41
TAOK3 Q9H2K8 2/20 0.41
DHODH Q02127 1/20 0.41
SIGMAR1 Q99720 2/20 0.39
TMEM97 Q5BJF2 1/20 0.39
GCGR P47871 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4788153 0.79 NOD1 (0.56) SCN9AKCNH2SCN5ACHRM2CHRM1
SCHEMBL4862497 0.76 SCN9A (0.42) MCHR1SCN9AKCNH2SCN5ACHRM4
SCHEMBL4862508 0.76 SCN9A (0.42) MCHR1SCN9AKCNH2SCN5ACHRM4
SCHEMBL4789135 0.75 KCNH2 (0.47) SCN9AKCNH2SCN5ASIGMAR1TMEM97
SCHEMBL4789166 0.74 KCNH2 (0.51) MCHR1SCN9AKCNH2SCN5AEPHX2
SCHEMBL4786534 0.71 MTNR1A (0.54) MCHR1SCN9AKCNH2SCN5AMTNR1A
SCHEMBL4788141 0.71 BRAF (0.41) SCN9AKCNH2SCN5A
SCHEMBL4787954 0.69 MEN1 (0.39)
SCHEMBL4746920 0.68 KCNH2 (0.61) MCHR1SCN9AKCNH2SCN5AMTNR1A
SCHEMBL3678482 0.68 MCHR1 (0.60) MCHR1TRPV1FAAHEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130319-A2 NOVEL N-TETRAHYDRONAPHTALENE OR N-CHROMANE CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO disclosed